Title: Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
Journal: The Journal of clinical investigation 20180601
Title: Discovery and clinical introduction of first-in-class imipridone ONC201.
Journal: Oncotarget 20161108
Title: Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.
Journal: Science translational medicine 20130206
Title: Allen JE, et al. Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects. Sci Transl Med. 2013 Feb 6;5(171):171ra17.